Click here for more information about Algenuity
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Evodos Separation Technology

Research

Chlamy — a cure for blindness?

September 10, 2015
AlgaeIndustryMagazine.com

Chlamydomona reinhardtii green algae. AMI Images/Science Source.

Chlamydomona reinhardtii green algae.

Sarah Zhang writes in Wired Magazine that the single-cell green algae Chlamydomonas reinhardtii have an eyespot that makes use of light-sensitive proteins. One of them is called channelrhodopsin-2. This algal protein, transplanted into the human retina, could one day restore sight to the blind. Last month, the FDA approved human clinical trials for the Ann Arbor-based company RetroSense to do just that.

For the past decade, neuroscientists have been using channelrhodopsin-2 to make neurons react to light. By genetically encoding the protein into neurons, scientists can easily probe brain circuits with light, a technique known as optogenetics.

RetroSense is planning to use optogenetics in humans for the first time, recruiting 15 patients blinded by the genetic eye disease retinitis pigmentosa for its clinical trial. “We are looking to get it off the ground this year in the fall,” says CEO Sean Ainsworth.

RetroSense will use a virus to insert copies of the channelrhodopsin-2 gene into neurons of the inner retina, which normally are not sensitive to light. (Rods and cones are the usual light-sensitive cells.)

RetroSense is licensing its technology from Zhuo-Hua Pan, a vision researcher at Wayne State University who studies how to restore sight when the rods and cones of the eye die off. That’s what happens in diseases like retinitis pigmentosa or age-related macular degeneration.

The obvious solution fixes human deficiencies with human genes: encode the light-sensitive proteins from human rods in the other functional cells in the diseased retina. But those proteins are finicky, and they have to work in concert with several other proteins – meaning scientists need to insert several genes. “We thought that would be almost impossible to do,” says Pan.

In 2003, Pan came across a paper on channelrhodopsin-2 from Chlamydomonas reinhardtii. Scientists started putting it into mammalian cells—and all they needed was one gene and one protein. “It worked perfectly, even in the very beginning,” says Pan. “That basically was just really, really lucky.” The hundreds of neuroscience labs relying on optogenetics might say the same.

Read More

More Like This…

HOME A.I.M. Archives

Copyright ©2010-2015 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Monica Jain of Fish 2.0 writes in National Geographic about how the algae brand is about to undergo an image makeover, and may soon seem flat-out glamorous — once again. ...
David Erickson writes in the (Montana) Missoulian that Clearas Water Recovery, a Missoula tech company formed eight years ago, has developed a patented process to use alg...
Washington State University researchers have developed a biofilm reactor to grow algae more efficiently, and make the algae more viable for several industries, including ...
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating arthritis. This is based on a polysaccharide, a long-c...
Colorado State University scientists and Arizona State University’s Arizona Center for Algae Technology and Innovation are partners in a three-year grant of up to $3.5 mi...
Portuguese microalgae producer, Allmicroalgae Natural Products S.A., has recently begun production of Chlorella vulgaris and other microalgae species via fermentation, wh...
Jeff Gelsky writes in Meat+Poultry that Corbion executives have given insights on how its September 29 acquisition of TerraVia Holdings Inc., an algae-based ingredients c...
The Natural Algae Astaxanthin Association (NAXA), headquartered in Spring, Texas, has announced that Chile-based Atacama Bio is its newest executive member. Atacama Bio h...
Amy Thompson writes in Space.com that SpaceX successfully launched its 15th Space Station cargo-resupply mission on Friday, June 29; carrying a payload of experiments des...
Environmental Technology magazine notes that the difficulty in predicting how algae blooms will develop lies in their variform nature. With a multitude of different bloom...
E.A. Crunden writes in thinkprogress.org that Florida’s first gubernatorial debate was dominated by environmental and climate issues, with an emphasis on the state’s alga...
Julianna Photopoulos writes in Horizon EU Research and Innovation magazine that UK start-up Skipping Rocks Lab aims to use natural materials extracted from plants and sea...